Thursday 31 December 2020
Glycemic control in type 1 diabetes improved during lockdown
(HealthDay)—On average, glycemic control improved during lockdown among people living with type 1 diabetes, according to a study published online Dec. 23 in Diabetes Care.
Cardiovascular risk up with metabolic syndrome in psoriasis
(HealthDay)—Metabolic syndrome (MetSyn) is prevalent among patients with psoriasis and is associated with increased cardiovascular risk, according to a study published online Dec. 28 in the Journal of the American Academy of Dermatology.
Which exercise regimen works best to ease lower back pain?
Chronic lower back pain can make the most routine tasks difficult. But a new study suggests patients can learn new, practical and less painful ways to move through individualized "motor skills training," or MST.
With pot rules relaxed, more U.S. teens driving while high: study
(HealthDay)—America's roads are notoriously unsafe on New Year's Eve, and a new study shows that marijuana legalization could be making the situation even worse.
Ring in the new year with a 'Mocktail'
WEDNESDAY, Dec. 30, 2020 (American Heart Association News)—At a time when many people are stress-drinking, a New Year's Eve sangria that's alcohol-free is a healthy way to say farewell to 2020.
Study of virus screening at concert reports zero infections
The organizers of an indoor music festival in Barcelona to test the effectiveness of same-day coronavirus screening said Wednesday that preliminary results indicate there was zero transmission inside the venue.
Well-preserved Ice Age woolly rhino found in Siberia
A well-preserved Ice Age woolly rhino with many of its internal organs still intact has been recovered from permafrost in Russia's extreme north.
Facebook to close Irish units at center of tax dispute
Facebook confirmed Wednesday it was closing its Irish subsidiaries at the center of a dispute on profit shifting to avoid taxes in the United States.
Amazon to buy hit podcast producer Wondery
Amazon said Wednesday it signed a deal to acquire the hit podcast production firm Wondery, in a move which boosts the US tech giant's efforts to round out its offerings from its music platform.
Indonesia in $9.8 bln electric vehicle battery deal with Korea's LG
Indonesia said Wednesday it had signed a $9.8 billion electric vehicle battery deal with South Korea's LG as it moves to become a global production hub for the green technology.
Eastern Caribbean issues rare alerts for rumbling volcanoes
Volcanoes that have been quiet for decades are rumbling to life in the eastern Caribbean, prompting officials to issue alerts in Martinique and St. Vincent and the Grenadines as scientists rush in to study activity they say hasn't been observed in years.
US expects to approve UK-backed AstraZeneca-Oxford vaccine in April
The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.
Canada to require negative Covid-19 test for entry
Canada will require travellers to obtain a negative Covid-19 test before being allowed into the country, the government announced Wednesday.
AstraZeneca vaccine approval unlikely in January: EU
The coronavirus vaccine developed by AstraZeneca and Oxford University, which was approved Wednesday in Britain, is unlikely to get a green light in the European Union in the next month, according to the European Medicines Agency (EMA).
US hits record daily Covid-19 deaths as world looks to vaccines in 2021
The US logged its highest ever daily death toll from the coronavirus Wednesday as the world prepares to turn the page on a grim year defined by the pandemic, with much of the globe united in one hope for 2021: that a slew of new vaccines will stamp out COVID-19.
Germany set for longer lockdown as death figures spike
German officials made clear Wednesday that they won't be able to relax lockdown restrictions in early January as the country recorded more than 1,000 deaths in one day for the first time.
China's first vaccine hustled to market as race to inoculate 1.3bn speeds up
China has granted "conditional" market approval to a Sinopharm vaccine with a reported 79 percent efficacy rate against COVID-19, health authorities said Thursday, a major stride towards inoculating the world's largest population.
Brain damage of patients with Covid-19
In an in-depth study of how COVID-19 affects a patient's brain, National Institutes of Health researchers consistently spotted hallmarks of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting the disease. In addition, they saw no signs of SARS-CoV-2 in the tissue samples, suggesting the damage was not caused by a direct viral attack on the brain. The results were published as a correspondence in the New England Journal of Medicine.
Moving due to unaffordable housing may jeopardize healthcare
People who move due to unaffordable housing are at increased risk of failing to receive the medical care they need, according to a new study from Cedars-Sinai and the University of California, Los Angeles. The study, published online in the Journal of General Internal Medicine, concludes that the result could be long-term health problems.
Published data from Moderna COVID-19 vaccine trial show 94.1 percent efficacy
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc. Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine can prevent symptomatic infection. Among the more than 30,000 participants randomized to receive the vaccine or a placebo, 11 of those in the vaccine group developed symptomatic COVID-19 compared to 185 participants who received the placebo, demonstrating 94.1 percent efficacy in preventing symptomatic COVID-19. Cases of severe COVID-19 occurred only in participants who received the placebo.
How did trauma centers respond to COVID-19? New processes provide care to trauma patients while keeping providers safe
As the COVID-19 pandemic emerged, trauma centers faced unprecedented obstacles to providing care for injured patients. A look at steps taken by trauma centers in response to COVID-19 is provided by a survey in the January/February Journal for Healthcare Quality (JHQ), the peer-reviewed journal of the National Association for Healthcare Quality (NAHQ).
Higher red cell transfusion threshold offers no advantage for treating preterm infants
Very low birthweight infants often need blood transfusions to survive. A National Institutes of Health-funded study suggests that providing a higher threshold of red cells within accepted limits offers no advantage in survival or reduction in neurological impairment over a lower threshold. The research was conducted by Haresh Kirpalani, B.M., of the University of Pennsylvania, Philadelphia, and colleagues and was funded by the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute, and National Center for Advancing Translational Sciences. The study appears in The New England Journal of Medicine.
Subscribe to:
Posts (Atom)